Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04653246
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2020-11-27
Brief Title:
Isatuximab Lenalidomide Bortezomib and Dexamethasone in NDMM
Sponsor:
Jacob Laubach MD
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-13
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-27
First Submit QC Date:
November 27 2020
Study First Post Date:
2020-12-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-31
Last Update Post Date:
2024-06-03
Last Update Post Date Type:
ACTUAL